KCI   Report issue

For profit
Founded: Singapore Singapore (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2018
NCT03722485
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

KCI USA, Inc.